Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial-Reference-Cited by-同舟云学术

Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial

Published:2015-05 Issue:9979 Volume:385 Page:1748-1757
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Buyse Gunnar M,Voit Thomas,Schara Ulrike,Straathof Chiara S M,D'Angelo M Grazia,Bernert Günther,Cuisset Jean-Marie,Finkel Richard S,Goemans Nathalie,McDonald Craig M,Rummey Christian,Meier Thomas

Publisher

Elsevier BV

Subject

General Medicine

Reference40 articles.

1. Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy;Mendell;Muscle Nerve,2013

2. Pulmonary function in Duchenne muscular dystrophy related to stage of disease;Inkley;Am J Med,1974

3. Respiratory function in the muscular dystrophies;Rideau;Muscle Nerve,1981

4. Profiles of neuromuscular diseases. Duchenne muscular dystrophy;McDonald;Am J Phys Med Rehabil,1995

5. Lung function in children with Duchenne's muscular dystrophy;Tangsrud;Resp Med,2001

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GLP-1R mediates idebenone-reduced blood glucose in mice;Biomedicine & Pharmacotherapy;2024-09

2. Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response;Cells;2024-07-09

3. Molecular and Biochemical Therapeutic Strategies for Duchenne Muscular Dystrophy;Neurology International;2024-07-05

4. Idebenone alleviates doxorubicin-induced cardiotoxicity by stabilizing FSP1 to inhibit ferroptosis;Acta Pharmaceutica Sinica B;2024-06

5. Muscular Dystrophy;Care of Adults with Chronic Childhood Conditions;2024